{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:55:50Z","timestamp":1788872150527,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2012R1A1A1002559"],"award-info":[{"award-number":["2012R1A1A1002559"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.urolonc.2014.10.015","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T09:44:28Z","timestamp":1420451068000},"page":"111.e9-111.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Murine \u03b2-defensin-2 may regulate the effect of bacillus Calmette-Gu\u00e9rin (BCG) in normal mouse bladder"],"prefix":"10.1016","volume":"33","author":[{"given":"Jong Kyou","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Hoon","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Ja","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kijeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ho","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2014.10.015_bib1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/014107680109400305","article-title":"BCG immunotherapy for superficial bladder cancer","volume":"94","author":"Lockyer","year":"2001","journal-title":"J R Soc Med"},{"key":"10.1016\/j.urolonc.2014.10.015_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/bju.12196","article-title":"Human beta-defensin 2 may inhibit internalisation of bacillus Calmette-Gu\u00e9rin (BCG) in bladder cancer cells","volume":"112","author":"Kim","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2014.10.015_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3346\/jkms.2014.29.3.343","article-title":"Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the mammalian target of rapamycin signaling pathway","volume":"29","author":"Kim","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.urolonc.2014.10.015_bib5","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1128\/JCM.00939-10","article-title":"Development and application of multiprobe real-time PCR method targeting the hsp65 gene for differentiation of Mycobacterium species from isolates and sputum specimens","volume":"48","author":"Kim","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib6","first-page":"1762","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of bacillus Calmette-Gu\u00e9rin","volume":"47","author":"Ratliff","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2014.10.015_bib7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0022-5347(17)38622-6","article-title":"Internalization of bacille Calmette-Gu\u00e9rin by bladder tumor cells","volume":"145","author":"Becich","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3892\/mmr.2012.1005","article-title":"Expression of hBD-2 induced by 23-valent pneumococcal polysaccharide vaccine, Haemophilus influenzae type b vaccine and split influenza virus vaccine","volume":"6","author":"Shen","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.urolonc.2014.10.015_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2014.10.015_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2172-8-6","article-title":"Discriminators of mouse bladder response to intravesical bacillus Calmette-Gu\u00e9rin (BCG)","volume":"8","author":"Saban","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00299721","article-title":"Morphological aspects of the interaction of bacillus Calmette-Gu\u00e9rin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?","volume":"20","author":"Teppema","year":"1992","journal-title":"Urol Res"},{"key":"10.1016\/j.urolonc.2014.10.015_bib12","first-page":"390","article-title":"Improved method of direct microscopy for detection of acid-fast bacilli in sputum","volume":"32","author":"Aung","year":"2001","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.urolonc.2014.10.015_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-4362.2003.01461.x","article-title":"Polymerase chain reaction based detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli","volume":"42","author":"Hsiao","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.19.1.165-256.2006","article-title":"Real-time PCR in clinical microbiology: applications for routine laboratory testing","volume":"19","author":"Espy","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.urolonc.2014.10.015_bib15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2008.11.124","article-title":"Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus Calmette-Gu\u00e9rin therapy in patients with superficial bladder cancer","volume":"181","author":"Bisiaux","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Gu\u00e9rin immunotherapy for superficial bladder cancer","volume":"170","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1442-2042.2007.01696.x","article-title":"Intravesical instillation therapy with bacillus Calmette-Gu\u00e9rin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"14","author":"Shintani","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0022-5347(05)66410-5","article-title":"The fate of bacillus Calmette-Gu\u00e9rin after intravesical instillation","volume":"165","author":"Durek","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2014.10.015_bib19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","article-title":"Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin in superficial bladder cancer","volume":"34","author":"De Boer","year":"1992","journal-title":"Cancer Immunol Immunother"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143914003585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143914003585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:04:39Z","timestamp":1761041079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143914003585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1078143914003585"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2014.10.015","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine \u03b2-defensin-2 may regulate the effect of bacillus Calmette-Gu\u00e9rin (BCG) in normal mouse bladder","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2014.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}